Today, Uvax Bio announced a leadership transition. I am honored and excited to lead Uvax into this busy year with research collaborations in our core programs of HIV, Pandemic Flu, MERS and SARS-Cov-2! I want to thank our Co-founder Dr. Ji Li for guiding the company to the point where we are advancing in 4 disease states where the unmet medical need is high. https://lnkd.in/euGmK8dK
Uvax Bio
生物技术
Newark，Delaware 2,045 位关注者
Addressing global health challenges through innovative vaccines
关于我们
Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, La Jolla, CA, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform technology developed by Professor Jiang Zhu of Scripps Research to develop and commercialize B-cell focused, rapid antibody-eliciting, preventive vaccines for the most challenging diseases around the world. Our 1c-SApNP technology streamlines vaccine development and has delivered promising vaccine candidates to address global health challenges such as HIV, RSV/hMPV, PIV1-5, Ebola/Marburg, Lassa, coronaviruses including SARS-CoV, MERS-CoV and SARS-CoV-2, HCV, ZIKV/DENV, and non-viral diseases such as Malaria and Tuberculosis.
- 网站
-
https://uvaxbio.com
Uvax Bio的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- Newark，Delaware
- 类型
- 私人持股
- 创立
- 2018
地点
-
主要
获取路线
200 Biddle Ave
Unit 202
US，Delaware，Newark，19702
Uvax Bio员工
动态
-
Uvax Bio announced results from the first interim analysis from the phase 1 trial of our HIV-1 vaccines. Dosing is expected to be completed in December 2024. https://lnkd.in/eSXj3dkR
-
Uvax Bio recognizes HIV Vaccine Awareness Day. And we salute the various institutions and investigators who have contributed to the advancement of HIV vaccine research. We are proud to be among the dedicated research teams conducting clinical studies with HIV vaccines. #HVAD #HIVvaccine
-
-
Great interview with our Global Medical Lead, Pedro Garbes. MD, MSc. regarding our Uvax Bio Phase 1 HIV-1 vaccine study underway in Australia. https://lnkd.in/eHiBQjXF